High-dose naxitamab plus stepped-up dosing of GM-CSF for high-risk neuroblastoma (HR-NB): Efficacy against histologically-evident primary refractory metastases in bone marrow (BM) Meeting Abstract
| Authors: | Kushner, B. H.; Modak, S.; Basu, E. M.; Roberts, S. S.; Cheung, N. K. V. |
| Abstract Title: | High-dose naxitamab plus stepped-up dosing of GM-CSF for high-risk neuroblastoma (HR-NB): Efficacy against histologically-evident primary refractory metastases in bone marrow (BM) |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 541s |
| Language: | English |
| ACCESSION: | WOS:000487345803614 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.10024 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 10024 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work